Amid Headwinds, CVS Beats Street’s 3Q Earnings Estimate

CVS Health Corp., the parent company of insurance firm Aetna, reported solid results in the third quarter, beating Wall Street earnings projections. However, the company also acknowledged headwinds including declining Medicare Advantage Star Ratings, the loss of Centene Corp.’s PBM business, a major legal settlement over opioid overprescribing, and losses posted by newly acquired divisions.

The insurer reported $2.09 in adjusted earnings per share (EPS), beating the Wall Street consensus projection of $2.00. Executives project an end-of-year adjusted EPS of $8.55 to $8.65, slightly up from a previous projection of $8.40 to $8.60. Total revenues across the firm increased by 10% year over year to $81.2 billion.

0 Comments
© 2024 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

cvs-pharmacy-retail-location-front-of-store
August 12

CVS May Join Insurers’ Home Health Care M&A Spree

READ MORE
cvs-logo
August 5

Insurance, Retail Segments Help CVS Beat Expectations in Second Quarter

READ MORE
bull-on-wall-street
May 6

Aetna Is Star of the Show in CVS First-Quarter Financial Results

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today